Connect your AI

CalAmp CAMP Compensation and benefits

Compensation and benefits at other companies

Ionis PharmaceuticalsIONS

——

Polaryx Therapeutics, Inc. PLYX

——

Recursion Pharmaceuticals, Inc.RXRX

——

Other financials

Income statement

Revenue$1.3M+50.8%

Operating income-$13.1M+0.2%

Net income-$18.3M-47.4%

EPS (diluted)-$0.32+48.4%

Balance sheet

Cash & equivalents$100.8M+97.9%

Total debt$2.1M-73.2%

Total equity$30.9M-40.1%

Total assets$105.5M+68.0%

Cash flow

Operating cash flow-$11.0M+23.1%

CapEx--100%

Free cash flow-$11.0M+24.6%

Valuation

Market cap$226.92M+666%

Enterprise value$128.2M-3,860%

P/S57.7×+47.8×

Profitability

Operating margin-1,335.2%-512pp

Net margin-2,193.7%-581pp

FCF margin-1,254%—

Returns & leverage

Return on equity-209.3%—

Debt / equity0.1×-0.1×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by CalAmp in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: CalAmp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is CalAmp's compensation and benefits?: CalAmp (CAMP) reported compensation and benefits of $945K in Q1 2026.
How has CalAmp's compensation and benefits changed year-over-year?: CalAmp's compensation and benefits increased by 21.0% year-over-year, from $781K to $945K.